IOCB Tech Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 1

IOCB Tech General Information


Provider of research translation service intended for pharmaceutical, chemical and biotechnology research and development processes. The company's service matches results of the basic research work of scientists with the needs of commercial partners to bring new ideas in medicinal chemistry, material sciences, biology and other fields of chemistry to human use or technology market, enabling scientists and researchers to transform ideas into patents.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • Flemingovo Number 2
  • Prague, 166 10
  • Czech Republic
+420 220 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IOCB Tech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 21-Dec-2017 Completed Generating Revenue
To view IOCB Tech’s complete valuation and funding history, request access »

IOCB Tech Executive Team (1)

Name Title Board Seat Contact Info
Martin Fusek Ph.D Chief Executive Officer
To view IOCB Tech’s complete executive team members history, request access »

IOCB Tech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IOCB Tech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
i&i Prague Venture Capital Minority 000 0000 000000 0
To view IOCB Tech’s complete investors history, request access »